Identification of novel serum biomarkers in child nephroblastoma using proteomics technology

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Molecular Biology Reports

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11033-010-0149-4PMID 20369385
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteomic profiling of ovine serum by SELDI-TOF MS: optimisation, reproducibility and feasibility of biomarker discovery using routinely collected samples.

  2010cited by this paper
• Accuracy of CA 125 in the diagnosis of ovarian tumors: a quantitative systematic review.

  2009cited by this paper
• The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.

  2009cited by this paper
• Chronic exposure to exogenous matrilysin induces chemoresistance and enhances Bcl-2 expression in A549 lung adenocarcinoma cells

  2009cited by this paper
• The correlations between HPV16 infection and expressions of c-erbB-2 and bcl-2 in breast carcinoma

  2009cited by this paper
• Site‐specific analysis of N‐glycans on haptoglobin in sera of patients with pancreatic cancer: A novel approach for the development of tumor markers

  2008cited by this paper
• Concise handbook of familial cancer susceptibility syndromes - second edition.

  2008cited by this paper
• Does the pre-operative value of serum CA15-3 correlate with survival in breast cancer?

  2008cited by this paper
• Imaging accuracy and incidence of Wilms' and non-Wilms' renal tumors in children.

  2008cited by this paper
• Glycosylation status of haptoglobin in sera of patients with prostate cancer vs. benign prostate disease or normal subjects

  2008cited by this paper
• Proteomic studies of early-stage and advanced ovarian cancer patients.

  2008cited by this paper
• Circulating haptoglobin is an independent prognostic factor in the sera of patients with epithelial ovarian cancer.

  2007cited by this paper
• Pediatric cancers in the new millennium: dramatic progress, new challenges.

  2007cited by this paper
• Haptoglobin and posttranslational glycan‐modified derivatives as serum biomarkers for the diagnosis of nonsmall cell lung cancer

  2007cited by this paper
• Wilms tumor: progress and considerations for the surgeon.

  2007cited by this paper
• Biomarker discovery in breast cancer serum using 2‐D differential gel electrophoresis/ MALDI‐TOF/TOF and data validation by routine clinical assays

  2006cited by this paper
• The activation of Akt/PKB signaling pathway and cell survival

  2005cited by this paper
• 4 million neonatal deaths: when? Where? Why?

  2005cited by this paper
• Haptoglobin polymorphisms and iron homeostasis in health and in disease.

  2004cited by this paper
• Death during induction therapy and first remission of acute leukemia in childhood

  2004cited by this paper
• Progressive reduction in treatment‐related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI)

  2001cited by this paper
• Structure-function analysis of the antioxidant properties of haptoglobin.

  2001cited by this paper
• Haptoglobin: function and polymorphism.

  2000cited by this paper
• Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980–1997

  2000cited by this paper
• Long-term follow-up of the United Kingdom Medical Research Council protocols for childhood acute lymphoblastic leukaemia, 1980-1997. Medical Research Council Childhood Leukaemia Working Party.

  2000cited by this paper
• Diagnosis of prostate cancer: comparison of serum prostate specific antigen, digital rectal examination and transrectal ultrasonography.

  1997cited by this paper
• Biological and clinical significance of haptoglobin polymorphism in humans.

  1996cited by this paper
• Haptoglobin. A potential reporter molecule for glycosylation changes in disease.

  1995cited by this paper
• Haptoglobin. A potential reporter molecule for glycosylation changes in disease.

  1995cited by this paper
• Structure, hormonal regulation, and identification of the interleukin-6- and dexamethasone-responsive element of the rat haptoglobin gene

  1990cited by this paper

• Potential of Serum ApoC1 as a Noninvasive Biomarker for Breast Cancer Detection and Prognosis: A Prospective Case–Control Study

  2025cites this paper
• Classification of small blue round cell tumors by integrating peptide and N-glycan mass imaging spectrometric profiles.

  2025cites this paper
• Integrative proteogenomic characterization of Wilms tumor

  2025cites this paper
• Wilms’ Tumor: A Review of Clinical Characteristics, Treatment Advances, and Research Opportunities

  2025cites this paper
• A novel machine learning algorithm picks proteome signature to specifically identify

  2023cites this paper
• A novel machine learning algorithm selects proteome signature to specifically identify cancer exosomes

  2023cites this paper
• Apolipoprotein C1 promotes glioblastoma tumorigenesis by reducing KEAP1/NRF2 and CBS-regulated ferroptosis

  2022cites this paper
• The evaluation of serum lipid profile and apolipoprotein C-1 in the Iranian patients of Oral Squamous Cell Carcinoma

  2022cites this paper
• Lysosomal dysfunction and autophagy blockade contribute to autophagy-related cancer suppressing peptide-induced cytotoxic death of cervical cancer cells through the AMPK/mTOR pathway

  2020cites this paper
• Apolipoprotein C1 (APOC1) as a novel diagnostic and prognostic biomarker for gastric cancer.

  2019cites this paper
• Screening and identification of non-inflammatory specific protein markers in Wilms' tumor tissues.

  2019cites this paper
• RETRACTED ARTICLE: Wilms tumor-suppressing peptide inhibits proliferation and induces apoptosis of Wilms tumor cells in vitro and in vivo

  2019cites this paper
• Proteomics in pediatric cystic craniopharyngioma

  2017cites this paper
• Identification of differentially expressed inflammatory factors in Wilms tumors and their association with patient outcomes

  2017cites this paper
• Identification of proteins associated with pediatric bilateral Wilms tumor

  2016cites this paper
• Screening and identification of post-traumatic stress-related serum factors in children with Wilms' tumors

  2016cites this paper
• Screening and identification of apolipoprotein A-I as a potential hepatoblastoma biomarker in children, excluding inflammatory factors.

  2015cites this paper
• Detection of Serum Protein Biomarkers for the Diagnosis and Staging of Hepatoblastoma

  2015cites this paper
• Proteomic characterization of pediatric craniopharyngioma intracystic fluid by LC‐MS top‐down/bottom‐up integrated approaches

  2014cites this paper
• Identification of Apolipoprotein C-I as a Potential Wilms’ Tumor Marker after Excluding Inflammatory Factors

  2014cites this paper
• Kidney protein profiling of Wilms' tumor patients by analysis of formalin-fixed paraffin-embedded tissue samples.

  2014cites this paper
• Advances in MALDI Mass Spectrometry in Clinical Diagnostic Applications

  2013cites this paper
• Identification of Serum Protein Biomarkers in Biliary Atresia by Mass Spectrometry and Enzyme-linked Immunosorbent Assay

  2012cites this paper
• Discovery and identification of serum biomarkers of Wilms' tumor in mice using proteomics technology.

  2012cites this paper
• Identification of potential serum biomarkers for Wilms tumor after excluding confounding effects of common systemic inflammatory factors

  2011cites this paper
• Identification of new biomarkers of low-dose GH replacement therapy in GH-deficient patients.

  2011cites this paper
• Clinicopathological pattern and Annexin A2 and Cdc42 status in patients presenting with differentiation and lymphnode metastasis of esophageal squamous cell carcinomas

  2011cites this paper
• Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifying biomarkers of laryngeal carcinoma

  2011cites this paper
• Marqueurs de néphropathies

  2011cites this paper
• Proteomic identification of differentially-expressed proteins in esophageal cancer in three ethnic groups in Xinjiang

  2011cites this paper
• Profiling for novel proteomics biomarkers in neurodevelopmental disorders

  2011cites this paper